Document is current
Any future updates will be listed below
-
Authors
Forslund, Anna https://orcid.org/0009-0004-5296-9435
Haraldsson, Erik
Holmberg, Erik
Naredi, Peter
Rizell, Magnus
-
Funding
Funding for this research was provided by:
Cancerfonden (CAN 2018/664)
Vetenskapsrådet (ALFGBG-7229219)
University of Gothenburg
- License Information
-
More Information
Article History
Received: 6 September 2024
Accepted: 23 November 2024
First Online: 13 December 2024
Declarations
:
: None of the authors have any potential conflicts of interest to report. Dr Anna Forslund attended the ILCA 2022 Annual Conference on behalf of Roche AB. Dr Erik Haraldsson is a GallRiks regulatory board member. Dr Erik Holmberg, Dr Peter Naredi and Dr Magnus Rizell have no conflicts of interests or financial ties to disclose.
